In 2020, breast cancer ranked the most common type of cancer among Filipinos (27,163 new cases), followed by lung cancer (19,180). In terms of mortality, lung cancer ranks first followed by breast cancer in 2020 alone — with over 17,000 deaths and almost 10,000 deaths, respectively.
While the numbers can be alarming, patients have a strategic ally in fighting cancer — early screening and diagnosis. Cancer screening tests are designed to find cancers in their earliest stages, when the disease is most treatable.
In celebration of Breast Cancer Awareness this October and in preparation for Lung Cancer Awareness Month in November, Hope From Within, a multi-stakeholder cancer advocacy campaign spearheaded by MSD in the Philippines, spotlights the importance of testing and diagnosis in an episode of its cancer conversation series dubbed as ‘Tita Hope Talks: Winning vs Cancer through Accessible Testing & Diagnostics.
Breast cancer is sometimes found after symptoms appear, but many women with breast cancer have no symptoms. This is why regular breast cancer screening is so important. Breast cancer image testing includes mammograms, breast ultrasound, and breast MRI.
Meanwhile, some lung cancers can be found by screening, but most lung cancers are found because they are causing problems. The actual diagnosis of lung cancer is made by looking at a sample of lung cells in the lab.
A breakthrough screening test called biomarker testing provides a targeted treatment approach for cancer patients. Biomarker testing finds changes in your cancer that could help you and your doctor choose your cancer treatment.
To help address the financial needs of Filipinos who might have cancer, RA 11215 or otherwise known as the National Integrated Cancer Control Act (NICCA), seeks to provide resources targeted toward cancer prevention, control, and awareness, alongside further aiding affected people affected by cancer. The NICCA also seeks to widen the scope of PhilHealth’s benefits packages to primary care screening, diagnosis, and end-of-life care for all stages and types of cancers, for both children and adults.
The Department of Budget and Management (DBM) recently announced that the national government’s PHP529.2 million Cancer Assistance Fund may still be used until Dec. 31 this year.
The CAF is a mechanism under NICCA which seeks to provide integrated and holistic support to cancer treatment and management. It aims to complement and supplement existing financial support mechanisms exclusive for cancer patients, persons living with cancer, and cancer survivors.
Pursuant to the circular, the CAF will also fund outpatient and inpatient cancer control services, including but not limited to diagnostics, therapeutic procedures, and other cancer medicines needed for the treatment and management of cancer and its care-related components.
